T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$5.14B |
| 2 |
JPMorgan Chase
JPM
|
+$2.05B |
| 3 |
Atlassian
TEAM
|
+$2.04B |
| 4 |
NVIDIA
NVDA
|
+$1.97B |
| 5 |
Apple
AAPL
|
+$1.73B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.32B |
| 2 |
Microsoft
MSFT
|
+$2.74B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.74B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.9B |
| 5 |
Hilton Worldwide
HLT
|
+$1.79B |
Sector Composition
| 1 | Technology | 26.88% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.14% |
| 4 | Financials | 10.69% |
| 5 | Communication Services | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Madrigal Pharmaceuticals
MDGL
$9.63B
| $4.41M | ﹤0.01% |
44,899
-3,554
| -7% | -$349K |
|
1477
Murphy Oil
MUR
$3.68B
| $4.37M | ﹤0.01% |
108,235
-23,490
| -18% | -$949K |
|
1478
Oshkosh
OSK
$8.77B
| $4.34M | ﹤0.01% |
43,137
+1,984
| +5% | +$200K |
|
1479
Aecom
ACM
$16.8B
| $4.33M | ﹤0.01% |
56,367
+4,409
| +8% | +$339K |
|
1480
Axalta
AXTA
$6.75B
| $4.32M | ﹤0.01% |
175,583
+5,845
| +3% | +$144K |
|
1481
Relmada Therapeutics
RLMD
$52.8M
| $4.25M | ﹤0.01% |
+157,565
| New | +$4.25M |
|
1482
Jazz Pharmaceuticals
JAZZ
$7.65B
| $4.1M | ﹤0.01% |
26,366
+2,563
| +11% | +$399K |
|
1483
Helmerich & Payne
HP
$2.1B
| $4.06M | ﹤0.01% |
94,975
+8,493
| +10% | +$363K |
|
|
COHR
1484
DELISTED
Coherent Inc
COHR
| $4.06M | ﹤0.01% |
14,861
-1,899
| -11% | -$519K |
|
1485
ManpowerGroup
MAN
$1.78B
| $4.06M | ﹤0.01% |
43,174
+4,159
| +11% | +$391K |
|
1486
Seres Therapeutics
MCRB
$139M
| $4.05M | ﹤0.01% |
28,410
+382
| +1% | +$54.4K |
|
1487
Recursion Pharmaceuticals
RXRX
$2.11B
| $4.03M | ﹤0.01% |
562,190
-295,383
| -34% | -$2.11M |
|
1488
First Citizens BancShares
FCNCA
$25.5B
| $3.98M | ﹤0.01% |
5,981
+2,456
| +70% | +$1.63M |
|
|
GMS
1489
DELISTED
GMS Inc
GMS
| $3.96M | ﹤0.01% |
79,495
+865
| +1% | +$43K |
|
1490
Upstart Holdings
UPST
$6.07B
| $3.95M | ﹤0.01% |
36,244
+8,607
| +31% | +$939K |
|
1491
Reinsurance Group of America
RGA
$12.7B
| $3.95M | ﹤0.01% |
36,038
+2,285
| +7% | +$250K |
|
1492
Hancock Whitney
HWC
$5.36B
| $3.9M | ﹤0.01% |
74,737
+17,467
| +30% | +$911K |
|
1493
Medical Properties Trust
MPW
$3.08B
| $3.87M | ﹤0.01% |
182,820
+16,131
| +10% | +$341K |
|
|
TEAD
1494
Teads Holding Co. Common Stock
TEAD
$163M
| $3.85M | ﹤0.01% |
+359,168
| New | +$3.85M |
|
1495
Lear
LEA
$5.62B
| $3.85M | ﹤0.01% |
26,963
-1,015
| -4% | -$145K |
|
|
ALLK
1496
DELISTED
Allakos
ALLK
| $3.84M | ﹤0.01% |
673,736
+431,599
| +178% | +$2.46M |
|
1497
First Solar
FSLR
$21.6B
| $3.83M | ﹤0.01% |
45,698
+3,858
| +9% | +$323K |
|
1498
STAG Industrial
STAG
$6.77B
| $3.83M | ﹤0.01% |
92,562
+4,913
| +6% | +$203K |
|
|
AJRD
1499
DELISTED
Aerojet Rocketdyne Holdings, Inc.
AJRD
| $3.81M | ﹤0.01% |
96,835
+4,245
| +5% | +$167K |
|
1500
Brixmor Property Group
BRX
$8.57B
| $3.79M | ﹤0.01% |
146,946
+53,427
| +57% | +$1.38M |
|